« Previous
Next »
AJIC: American Journal of Infection Control
Volume 37, Issue 9
, Pages 715-722
, November 2009
Long-term control of hospital-wide, endemic multidrug-resistant Acinetobacter baumannii through a comprehensive “bundle” approach
References
- . and the National Nosocomial Infections Surveillance System. Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis. 2005;41:848–854
- . Multidrug-resistant Acinetobacter extremity infections in soldiers. Emerg Infect Dis. 2005;11:1218–1224
- Clinical features and epidemiology of Acinetobacter baumannii colonization and infection in Spanish hospitals. Infect Control Hosp Epidemiol. 2004;25:819–824
- . Cerda E y Grupo de estudio de vigilancia de infección nosocomial en UCI. Estudio Nacional de vigilancia de infección nosocomial en unidades de cuidados intensivos. Informe del año 2001. Med Intensiva. 2003;27:13–23
- . Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microb Rev. 1996;9:148–165
- . Mortality and the increase in length of stay attributable to the acquisition of Acinetobacter in critically ill patients. Crit Care Med. 1999;27:1794–1799
- Direct costs of multidrug-resistant Acinetobacter baumannii in the burn unit of a public teaching hospital. Am J Infect Control. 2004;32:342–344
- . Worldwide emergence of carbapenem-resistant Acinetobacter spp. J Antimicrob Chemother. 1998;41:576–577
- Citywide clonal outbreak of multiresistant Acinetobacter baumannii and Pseudomonas aeruginosa in Brooklyn, NY: the preantibiotic era has returned. Arch Intern Med. 2002;162:1515–1520
- . Acinetobacter outbreaks, 1977-2000. Infect Control Hosp Epidemiol. 2003;24:284–295
- Nosocomial Acinetobacter baumannii infections: microbiological and clinical epidemiology. Ann Intern Med. 1998;129:182–189
- Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii. J Clin Microbiol. 2000;38:4086–4095
- . Considerations in control and treatment of nosocomial infections due to multidrug-resistant Acinetobacter baumannii. Clin Infect Dis. 2003;36:1268–1274
- . Multidrug-resistant Acinetobacter baumannii. Emerg Infect Dis. 2005;11:22–29
- . Nosocomial bacteraemia due to Acinetobacter baumannii. Rev Med Microbiol. 1999;10:67–78
- . CDC definitions for nosocomial infections. Am J Infect Control. 1988;16:128–140
- . Prevalence of nosocomial infections in Spain: EPINE study 1990-1997. EPINE Working group. J Hosp Infect. 1999;43(Suppl):S105–S111
- Bacteriemias por Acinetobacter baumannii: características clínicas y pronósticas. Enferm Infecc Microbiol Clin. 2003;21:242–246
- Rodríguez Baño J, Ramírez E, Santos J, Martinez-Martinez L, Munian MA, Joyanes P, et al. Risk factors for colonization with Acinetobacter baumannii in the intensive care unit (abstract J-203). Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy (Toronto, Canada). Washington, DC: American Society for Microbiology; 1997. p. 326.
- . Guidelines for environmental infection control in health-care facilities: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR. 2003;52(No. RR-10):1–48
- . Taxonomy of the genus Acinetobacter with recognition of Acinetobacter baumannii sp. nov., Acinetobacter haemolyticus sp. nov., Acinetobacter johnsonii sp. nov., and Acinetobacter junii sp. nov. and emended descriptions of Acinetobacter calcoaceticus and Acinetobacter lwoffi. Int J Syst Bacteriol. 1986;36:228–240
- . Use of low-frequency-cleavage restriction endonucleases for DNA analysis in epidemiological investigations of nosocomial infections. J Clin Microbiol. 1989;27:2057–2061
- Interpreting chromosomal DNA restriction patterns by pulsed-field gel electrophoresis; criteria for bacteria strain typing. J Clin Microbiol. 1995;33:2233–2239
- Identification of Acinetobacter genomic species by amplified ribosomal DNA restriction analysis. J Clin Microbiol. 1995;33:11–15
- . Investigation of an outbreak of multi-drug resistant Acinetobacter baumannii in an intensive care burns unit. J Hosp Infect. 2001;48:228–232
- Environmental sampling of Acinetobacter baumannii: moistened swabs versus moistened sterile gauze pads. Infect Control Hosp Epidemiol. 1999;20:458–460
- Clinical and molecular epidemiology of Acinetobacter infections sensitive only to polymyxin B and sulbactam. Lancet. 1994;344:1329–1332
- Risk factors for nosocomial colonization with multiresistant Acinetobacter baumannii. Eur J Clin Microbiol Infect Dis. 1995;14:569–576
- . Bacteriological, clinical and epidemiological characteristics of hospital acquired Acinetobacter baumannii in a teaching hospital. J Hosp Infect. 2003;54:39–45
- . for the Thammasat University Pandrug-Resistant Acinetobacter baumannii Control Group. A multifaceted intervention to reduce pandrug-resistant Acinetobacter baumannii colonization and infection in 3 intensive care units in a Thai tertiary care center: a 3-year study. Clin Infect Dis. 2008;47:760–767
- . the Infectious Diseases Society of America Emerging Infections Network. Management of inpatients colonized or infected with antimicrobial-resistant bacteria in hospitals in the United States. Infect Control Hosp Epidemiol. 2005;26:138–143
- . Unusual genetic heterogeneity of Acinetobacter baumannii isolates in a university hospital in Italy. Am J Infect Control. 1999;27:247–253
- . The use and interpretation of quasi-experimental studies in infectious diseases. Clin Infect Dis. 2004;38:1586–1591
- Relevance of digestive tract colonization in the epidemiology of nosocomial infections due to multiresistant Acinetobacter baumannii. Clin Infect Dis. 1996;23:329–334
- . Survival of Acinetobacter baumannii on dry surfaces. J Clin Microbiol. 1997;35:1394–1397
- . Surveillance of an adult intensive care unit for long-term persistence of a multiresistant strain of Acinetobacter baumannii. Eur J Clin Microbiol Infect Dis. 1998;17:171–176
- . An outbreak of Acinetobacter baumannii: the importance of cross-transmission. Infect Control Hosp Epidemiol. 2000;21:588–591
L.M-M.'s present address is Servicio de Microbiología, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
Supported in part by the Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III-FEDER, Spanish Network for the Research in Infectious Diseases (REIPI C03/14 and REIPI RD06/0008), and FIS PI051019; a fellowship from the Asociación Sanitaria Virgen Macarena (to C.M.); the Merit Review Award and Geriatric Research Education and Clinical Center VISN 10 from the Department of Veterans Affairs and the NIH (RO1 AI072219; to R.A.B.); AstraZeneca (to A.E.); and a Wyeth Fellowship in Antimicrobial Resistance (to F.P.).
Conflicts of interest: None to report.
PII: S0196-6553(09)00106-0
doi: 10.1016/j.ajic.2009.01.008
« Previous
Next »
AJIC: American Journal of Infection Control
Volume 37, Issue 9
, Pages 715-722
, November 2009
